期刊文献+

狼疮肾炎患者尿蛋白通过p38丝裂素活化蛋白激酶信号途径刺激近端肾小管上皮细胞上调表达骨调素 被引量:4

Urinary protein of patients with lupus nephritis up-regulates OPN expression in HK-2 cells through p38 MAPK signaling pathway
原文传递
导出
摘要 目的探讨p38丝裂素活化蛋白激酶(MAPK)信号通路在狼疮肾炎(LN)尿蛋白介导近端肾小管上皮细胞(HK-2)表达骨调素(OPN)中的作用。方法收集狼疮肾炎患者24 h的尿液提纯总蛋白,体外刺激HK-2细胞,分别用逆转录-聚合酶链式反应(RT-PCR)和Western印迹法观察应用p38 MAPK特异性阻断剂SB203580对HK-2细胞表达OPN mRNA及蛋白的影响;免疫荧光法检测OPN及其受体CD44在细胞中的表达。结果狼疮肾炎患者尿蛋白可刺激HK-2 细胞OPN mRNA及蛋白上调表达,并呈时间和浓度依赖性,而SB203580可明显抑制这一作用。结论狼疮肾炎尿蛋白可通过p38 MAPK途径刺激HK-2细胞OPN mRNA和蛋白上调表达。 Objective To investigate the role of p38 mitogen-activated protein kinase (p38 MAPK) in up-regulating osteopontin (OPN) expression in human renal epithelial cells (HK-2) induced by urine protein which is isolated and purified from the urine of patients with lupus nephritis. Methods Protein was purified from the urine of six patients with lupus nephritis and incubated with HK-2 cells. OPN mRNA and protein expression were measured in HK-2 stimulated by urine protein with reverse transcription polymerase chain reaction (RT-PCR) and Western blotting, respectively. The specific inhibitor of p38 MAPK, SB203580 was used to test the effect of p38 MAPK in the expression of OPN. The location of OPN and its ligand CD44 was detected by immunofluorescence. Results OPN mRNA and protein were up-regulated in HK-2 cells induced by urine protein in dose- and time-dependent manner.SB203580 could inhibit the up-regulation of OPN induced by urine. Conclusion P38 MAPK may play an important role in up-regulating OPN in HK-2 cells induced by urine protein.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2005年第6期351-355,共5页 Chinese Journal of Nephrology
  • 相关文献

参考文献10

  • 1Agarwal A, Nath KA. Effect of proteinuria on renal interstitium:effect of products of nitrogen metabolism. Am J Nephrol,1993,13: 376-384.
  • 2Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol, 1994, 5: 1273-1287.
  • 3Largo R, Gomez GD, Soto K, et al. Angiotensin converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension, 1999 33: 732-739.
  • 4Eddy AA. Interstitial nephritis induced by protein overload proteinuria. Am J Pathol. 1989, 135: 719-733.
  • 5Eddy AA,Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria. Kidney Int, 1995,47:1546-1557.
  • 6Eddy AA, McCulloch L, Liu E ,et al. A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am J Pathol, 1991,138: 1111-1123.
  • 7Oldberg A, Franzen A, Heinegerd. Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg Gly Asp cell binding sequence. Proc Natl Acad Sci USA, 1986,83: 8819-8823.
  • 8Pichler R, Giachelli CM, Lombardi D, et al. Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin ( uropontin).Am J Pathol, 1994,144: 915-926.
  • 9余学清,孙玉玲,穆威,蓝辉耀.骨调素对巨噬细胞在新月体肾炎肾脏组织局部浸润的影响[J].中华肾脏病杂志,1998,14(4):220-224. 被引量:5
  • 10Junaid A, Amara FM. Osteopontin:correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancenment of expression by glucose in human proximal tubular epithelial cells. Histopathology, 2004,44:136-146.

共引文献4

同被引文献25

  • 1郭兵,肖瑛,万昌武,桂华珍,张国忠.糖尿病大鼠肾小管TGF-β_1和MAPK_(1/3)表达的动态观察[J].中国病理生理杂志,2004,20(9):1681-1685. 被引量:32
  • 2钟清,甘华,肖刚.特异性COX-2抑制剂对小鼠狼疮性肾炎CD14^+表达及TNF-α、IL-6的影响[J].重庆医科大学学报,2005,30(1):71-74. 被引量:1
  • 3臧敬五.自身免疫性疾病研究的新进展——骨桥蛋白在类风湿性关节炎中的病理机制研究[J].中国科学院院刊,2005,20(3):208-210. 被引量:53
  • 4Blom T,Franzen A,Heinegard D,et al. Comment on "The influence of the proinflammatory cytokine,osteopontin,on autoimmune demyelinating disease"[J]. Science,2003,299(5614):1845.
  • 5Ashkar S,Weber G F,Panoutsakopoulou V,et al. Eta-1(osteopontin):an early component of type-1 (cell-mediated) immunity[J]. Science, 2000,287 ( 5454 ) :860-864.
  • 6Ophascharoensuk V,Giachelli C M,Gordon K,et al. Obstructive uropathy in the mouse:role of osteopontin in interstitial fibrosis and apoptosis[J]. Kidney Int,1999,56(2):571-580.
  • 7Tan E M,Cohen A S,Fries J F,et al. The 1982 revised crite ria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1982,25 ( 11 ):1271-1277.
  • 8Chabas D,Baranzini S E,Mitchell D,et al. The influence of the proinflammatory cytokine,osteopontin,on autoimmune demyelinating disease[J]. Science,2001,29g(5547):1731-1735.
  • 9Aringer M,Smolen JS.Tumor necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus:a rationale for therapeutic intervention[J]. Lupus,2004,13(5):344-347.
  • 10Wong C K,Lit L C,Tam L S,et al. Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus[J]. Rheumatology,2005,44(5):602- 606.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部